X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
humans (23) 23
female (17) 17
middle aged (17) 17
aged (15) 15
male (14) 14
chemotherapy (13) 13
adult (11) 11
oncology (11) 11
breast cancer (9) 9
prognosis (9) 9
analysis (7) 7
cancer (7) 7
care and treatment (7) 7
fluorouracil (7) 7
retrospective studies (7) 7
survival (7) 7
aged, 80 and over (6) 6
colorectal cancer (6) 6
dpyd (6) 6
medicine (6) 6
medicine & public health (6) 6
pharmacology & pharmacy (6) 6
research (6) 6
treatment outcome (6) 6
cancer patients (5) 5
cancer therapies (5) 5
early recurrence (5) 5
original (5) 5
original article (5) 5
pancreatic adenocarcinoma (5) 5
pancreatic neoplasms (5) 5
polymorphism, single nucleotide (5) 5
thymidylate synthase (5) 5
5-fluorouracil degradation rate (4) 4
antineoplastic agents - therapeutic use (4) 4
biomarkers (4) 4
capecitabine (4) 4
case report (4) 4
cell biology (4) 4
cell lung-cancer (4) 4
fluorouracil - adverse effects (4) 4
fluorouracil - pharmacokinetics (4) 4
genetic polymorphisms (4) 4
immunotherapy (4) 4
medicine, research & experimental (4) 4
metastases (4) 4
metastasis (4) 4
methylenetetrahydrofolate reductase - genetics (4) 4
patients (4) 4
polymorphisms (4) 4
reductase gene polymorphisms (4) 4
thymidylate synthase - genetics (4) 4
toxicity (4) 4
tumors (4) 4
usage (4) 4
variants (4) 4
adenocarcinoma (3) 3
adjuvant chemotherapy (3) 3
antimetabolites, antineoplastic - adverse effects (3) 3
antimetabolites, antineoplastic - pharmacokinetics (3) 3
colorectal neoplasms - drug therapy (3) 3
development and progression (3) 3
dihydrouracil dehydrogenase - genetics (3) 3
docetaxel (3) 3
drug therapy (3) 3
enzymes (3) 3
genotype (3) 3
impact (3) 3
internal medicine (3) 3
medical prognosis (3) 3
mthfr (3) 3
multidisciplinary sciences (3) 3
multivariate analysis (3) 3
neoplasm staging (3) 3
nomogram (3) 3
oncologie [sciences de la santé humaine] (3) 3
oncology [human health sciences] (3) 3
outcomes (3) 3
preoperative ca 19-9 (3) 3
prognostic factors (3) 3
proteins (3) 3
research article (3) 3
research paper (3) 3
5-fluorouracil (2) 2
5-fu degradation rate (2) 2
5-fu toxicity (2) 2
adaptation, psychological (2) 2
adenocarcinoma - therapy (2) 2
adjuvant hormonal therapy (2) 2
animals (2) 2
anti-pd-1 (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
aromatase inhibitor (2) 2
beyond progression (2) 2
cell line, tumor (2) 2
chemotherapy, adjuvant (2) 2
clinical case report (2) 2
clinical research paper (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Vaccaro, Olga and Masulli, Maria and Nicolucci, Antonio and Bonora, Enzo and Del Prato, Stefano and Maggioni, Aldo P and Rivellese, Angela A and Squatrito, Sebastiano and Giorda, Carlo B and Sesti, Giorgio and Mocarelli, Paolo and Lucisano, Giuseppe and Sacco, Michele and Signorini, Stefano and Cappellini, Fabrizio and Perriello, Gabriele and Babini, Anna Carla and Lapolla, Annunziata and Gregori, Giovanna and Giordano, Carla and Corsi, Laura and Buzzetti, Raffaella and Clemente, Gennaro and Di Cianni, Graziano and Iannarelli, Rossella and Cordera, Renzo and La Macchia, Olga and Zamboni, Chiara and Scaranna, Cristiana and Boemi, Massimo and Iovine, Ciro and Lauro, Davide and Leotta, Sergio and Dall'Aglio, Elisabetta and Cannarsa, Emanuela and Tonutti, Laura and Pugliese, Giuseppe and Bossi, Antonio C and Anichini, Roberto and Dotta, Francesco and Di Benedetto, Antonino and Citro, Giuseppe and Antenucci, Daniela and Ricci, Lucia and Giorgino, Francesco and Santini, Costanza and Gnasso, Agostino and De Cosmo, Salvatore and Zavaroni, Donatella and Vedovato, Monica and Consoli, Agostino and Calabrese, Maria and di Bartolo, Paolo and Fornengo, Paolo and Riccardi, Gabriele and Vaccaro, Olga and Masulli, Maria and Nicolucci, Antonio and Maggioni, Aldo Pietro and Sesti, Giorgio and Mocarelli, Paolo and Lucisano, Giuseppe and Sacco, Michele and Signorini, Stefano and Cappellini, Fabrizio and Riccardi, Gabriele and Boemi, Massimo and D'Angelo, Federica and Giansanti, Roberto and Tanase, Laura and Lanari, Luigi and Testa, Ivano and Ricci, Lucia and Pancani, Francesca and Ranchelli, Anna and Vagheggi, Paolo and Scatona, Alessia and Fontana, Lucia and Giorgino, Francesco and Laviola, Luigi and Tarantino, Lucia and Ippolito, Claudia and Gigantelli, Vittoria and Manicone, Mariangela and Conte, Eleonora and Trevisan, Roberto and Scaranna, Cristiana and Rota, Rossella and Corsi, Anna and Dodesini, Alessandro R and Reggiani, Giulio Marchesini and Montesi, Luca and Mazzella, Natalia and Forlani, Gabriele and Caselli, Chiara and Di Luzio, Raffaella and Mazzotti, Arianna and Aiello, Antimo and Barrea, Angelina and Musto, Antonio and ... and Italian Diabetes Society and Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group and Thizolidinediones Sulfonylureas Ca
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 11/2017, Volume 5, Issue 11, pp. 887 - 897
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e15021 - e15021
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e15020 - e15020
Journal Article
by Mercadante, Sebastiano and Mercadante, Sebastiano and Marchetti, Paolo and Marchetti, Paolo and Cuomo, Arturo and Cuomo, Arturo and Caraceni, Augusto and Caraceni, Augusto and Mediati, Rocco Domenico and Mediati, Rocco Domenico and Mammucari, Massimo and Mammucari, Massimo and Natoli, Silvia and Natoli, Silvia and Lazzari, Marzia and Lazzari, Marzia and Dauri, Mario and Dauri, Mario and Airoldi, Mario and Airoldi, Mario and Azzarello, Giuseppe and Azzarello, Giuseppe and Bandera, Mauro and Bandera, Mauro and Blasi, Livio and Blasi, Livio and Cartenì, Giacomo and Cartenì, Giacomo and Chiurazzi, Bruno and Chiurazzi, Bruno and Costanzo, Benedetta Veruska Pierpaola and Costanzo, Benedetta Veruska Pierpaola and Degiovanni, Daniela and Degiovanni, Daniela and Fusco, Flavio and Fusco, Flavio and Guardamagna, Vittorio and Guardamagna, Vittorio and Iaffaioli, Vincenzo and Iaffaioli, Vincenzo and Liguori, Simeone and Liguori, Simeone and Lorusso, Vito and Lorusso, Vito and Mameli, Sergio and Mameli, Sergio and Mattioli, Rodolfo and Mattioli, Rodolfo and Mazzei, Teresita and Mazzei, Teresita and Melotti, Rita Maria and Melotti, Rita Maria and Menardo, Valentino and Menardo, Valentino and Miotti, Danilo and Miotti, Danilo and Moroso, Stefano and Moroso, Stefano and De Santis, Stefano and De Santis, Stefano and Orsetti, Remo and Orsetti, Remo and Papa, Alfonso and Papa, Alfonso and Ricci, Sergio and Ricci, Sergio and Sabato, Alessandro Fabrizio and Sabato, Alessandro Fabrizio and Scelzi, Elvira and Scelzi, Elvira and Sofia, Michele and Sofia, Michele and Tonini, Giuseppe and Tonini, Giuseppe and Aielli, Federica and Aielli, Federica and Valle, Alessandro and Valle, Alessandro and IOPS MS Study Grp and IOPS MS study group and On behalf of the IOPS MS study group
Advances in Therapy, ISSN 0741-238X, 1/2017, Volume 34, Issue 1, pp. 120 - 135
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2015, Volume 112, Issue 46, pp. 14331 - 14336
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 11/2019, Volume 862, p. 172621
Melanoma onset and progression are associated with a high variety of activating mutations in the MAPK-pathway, most frequently involving BRAF (35–45%) and NRAS... 
MEK | BRAF | Target therapy | Immunotherapy | Melanoma | Mechanisms of resistance | PLUS COBIMETINIB C | BRAF(V600E) INHIBITION | ACQUIRED-RESISTANCE | RAF KINASE | ANTITUMOR-ACTIVITY | METASTATIC MELANOMA | MEL UPDATED SAFETY | CUTANEOUS MELANOMA | PHARMACOLOGY & PHARMACY | MAPK PATHWAY | TUMOR MICROENVIRONMENT | Skin Neoplasms - drug therapy | TOR Serine-Threonine Kinases - metabolism | Humans | MicroRNAs - metabolism | Antineoplastic Agents - therapeutic use | MAP Kinase Signaling System - genetics | Tumor Microenvironment - genetics | Melanoma - genetics | Antineoplastic Agents - pharmacology | Epigenesis, Genetic - drug effects | Gain of Function Mutation | Gene Expression Regulation, Neoplastic - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Molecular Targeted Therapy - methods | Skin Neoplasms - pathology | Tumor Microenvironment - drug effects | Treatment Outcome | Clinical Trials as Topic | Melanoma - pathology | Disease Progression | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Drug Resistance, Neoplasm - genetics | MAP Kinase Signaling System - drug effects | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects
Journal Article
Oncotarget, ISSN 1949-2553, 05/2018, Volume 9, Issue 39, pp. 25714 - 25722
Sarcopenia refers to the reduction of both volume and number of skeletal muscle fibers. Lean body mass loss is associated with survival, quality of life and... 
Lean body mass | Sarcopenia | Adjuvant chemotherapy | Breast cancer | Anthracyclines toxicity
Journal Article
Medical Oncology, ISSN 1357-0560, 7/2018, Volume 35, Issue 7, pp. 1 - 9
This study aimed to identify clinicopathological factors associated with the outcome of elderly patients with gastric cancer (GC), and to construct a nomogram... 
Pathology | Chemotherapy | Prognosis | Medicine & Public Health | Hematology | Nomogram | Oncology | Internal Medicine | Gastric cancer | Older adults | Elderly | MORTALITY | RESECTION | OLDER | IMPACT | LYMPHADENECTOMY | ONCOLOGY | OUTCOMES | AGE | Aged patients | Cancer patients | Stomach cancer | Patient outcomes | Analysis | Medical prognosis | Surgery
Journal Article